NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIA E-092-2011-0-GB-01 The Use Of (2R,6R)-Hydroxynorketamine, (S)-Dehydronorketamine And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain GB EP 21177619.0 Pending
NIA E-092-2011-0-EP-13 The Use Of (2R,6R)-Hydroxynorketamine, (S)-Dehydronorketamine And Other Stereoismeric Dehydro And Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression And Neuropathic Pain EP DIV 21177619.0 Pending
NCI E-108-2021-0-US-01 COMBINATION IMMUNOTHERAPY FOR THE TREATMENT OF GLYPICAN-3 (GPC3)-EXPRESSING TUMORS US 63/196,556 Abandoned
NCATS E-040-2021-0-US-01 Method To Screen Libraries By Multiplex Gene Expression US 63/196,438 Abandoned
NCI E-219-2013-1-US-01 USE OF CYSTEAMINE AND DERIVATIVES THEREOF TO SUPPRESS TUMOR METASTASES US CON 17/337,095 11844769 Issued PDF
NCATS E-169-2019-0-PCT-02 DIFFERENTIATION OF TROPHECTODERM LINEAGE CELLS FROM PLURIPOTENT STEM CELLS PCT PCT PCT/US2021/035527 Expired
NCI E-099-2014-0-JP-13 MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF JP DIV 2021-090964 Issued
NCI E-171-2018-7-GB-10 MODIFIED CELLS AND METHODS OF THERAPY GB DIV 2107650.0 Issued
NCI E-171-2018-7-GB-09 MODIFIED CELLS AND METHODS OF THERAPY GB DIV 2107651.8 Issued
NEI E-033-2021-0-PCT-02 EXOSOMES COMPRISING IL-35 OR IL-27 AND USES THEREOF PCT PCT PCT/US2021/034778 Expired
NEI E-247-2020-0-PCT-02 BILAYER OF RETINAL PIGMENTED EPITHELIUM AND PHOTORECEPTOR PRECURSORS PCT PCT PCT/US2021/034851 Expired
NEI E-153-2020-0-US-01 BIODEGRADABLE TISSUE SCAFFOLD WITH SECONDARY MATRIX TO HOST WEAKLY ADHERENT CELLS US 63/194,770 Abandoned
NEI E-155-2020-0-US-01 METHODS TO GENERATE MACULAR, CENTRAL AND PERIPHERAL RETINAL PIGMENT EPITHELIAL CELLS US 63/194,774 Abandoned
NCI E-282-2016-2-NZ-02 METHODS OF CONDITIONING PATIENTS FOR T CELL THERAPY NZ DIV 776617 Issued
NIAID E-021-2019-0-US-20 CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN US CON 17/332,901 11993633 Issued PDF
NCI E-031-2021-0-US-01 NITROXIDE RADICALS AS ANTIVIRAL TREATMENT FOR CORONAVIRUS INFECTION US 63/193,656 Abandoned
NCI E-042-2014-0-MX-28 Chimeric Antigen Receptors Targeting CD-19 MX DIV MX/a/2021/006239 Pending
NCI E-127-2018-0-CA-01 Compositions and Methods for Treating Cancer with Anti-CD38 Immunotherapy CA National Stage 3121244 Pending
NCI E-150-2017-2-NZ-01 Diagnostic Methods For T Cell Therapy NZ DIV 776400 Pending
NCI E-150-2017-2-NZ-02 Diagnostic Methods For T Cell Therapy NZ DIV 776402 Pending
NCI E-282-2016-2-NZ-01 METHODS OF CONDITIONING PATIENTS FOR T CELL THERAPY NZ DIV 776615 Pending
NCI E-184-2020-0-PCT-02 TARGETING THE CHOLECYSTOKININ-B RECEPTOR FOR IMAGING AND EARLY DETECTION OF PANCREATIC CANCER AND PRE-CANCEROUS LESIONS PCT PCT PCT/US2021/034339 Expired
NHLBI E-149-2018-0-US-03 Use Of VDAC Inhibitor VBIT 4 In Lupus Treatment US National Stage 17/297,017 Pending
CC E-026-2015-0-US-02 SYSTEM AND METHOD FOR PLANNING AND PERFORMING A REPEAT INTERVENTIONAL PROCEDURE US CON 17/329,216 11950967 Issued PDF
NCI E-042-2014-0-IL-29 Chimeric Antigen Receptors Targeting CD-19 IL DIV 283423 Issued
NIDDK E-112-2021-0-US-01 Vitamin C Renal Leak As A Clinical Diagnostic Tool In The Detection, Monitoring And Management Of Acute And Chronic Diseases US 63/193,012 Abandoned
NICHD E-028-2020-0-US-01 TAMPERLESS TENSOR ELASTOGRAPHY IMAGING US 63/192,920 Abandoned
NCI E-008-2014-2-JP-16 Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same JP DIV 2021-086485 Issued
NCI E-166-2018-0-EP-07 HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS EP National Stage 19805442.1 Issued
NCI E-096-2021-0-US-01 LABELING BIOLOGICAL PARTICLES USING ACOUSTOPHORESIS US 63/191,103 Abandoned
NCATS E-139-2021-0-US-01 REACTION DATA MANAGEMENT (RDM) ARCHITECTURE FOR SECURE STORAGE AND EXCHANGE OF CHEMICAL INFORMATION US 63/190,687 Abandoned
NIAID E-260-2014-0-US-06 RECOMBINANT METAPNEUMOVIRUS F PROTEINS AND THEIR USE US DIV 17/334,505 11786591 Issued PDF
NCI E-029-2022-1-PCT-02 Compositions And Methods For Prevention Of Coronavirus Infection PCT PCT PCT/US2021/033009 Expired
NCI E-029-2022-1-US-02 Compositions And Methods For Prevention Of Coronavirus Infection US National Stage 17/999,235 Pending
NIBIB E-047-2019-0-US-07 CONJUGATES OF BIVALENT EVANS BLUE DYE DERIVATIVES AND METHODS OF USE US National Stage 17/294,914 Issued
NEI E-015-2019-0-US-11 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE US National Stage 17/295,030 Pending
CC E-128-2020-0-US-02 ISOLATION DEVICES TO REDUCE CONTAMINATION DURING IMAGING OF PATIENTS US ORD 17/323,763 Pending
NCI E-029-2022-1-EP-01 Compositions And Methods For Prevention Of Coronavirus Infection EP National Stage 21809656.8 Pending
NIDDK E-028-2018-1-HK-08 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS HK National Stage 62021031364.4 Abandoned
NCATS E-035-2020-1-US-02 TREATING PRIMARY OR IDIOPATHIC HYPEROXALURIA WITH SMALL MOLECULE INHIBITORS OF LACTATE DEHYDROGENASE US ORD 17/322,260 11752138 Issued PDF
NCI E-257-2009-1-US-26 Use Of IL-15 To Increase Thymic Output US CON 17/322,086 Abandoned
NIAID E-128-2021-0-PCT-02 COMPOSITIONS, SYSTEMS, AND METHODS FOR GENERATING GENE-EDITED CELLS PCT PCT PCT/US2021/032782 Expired
NIAAA E-087-2021-0-US-01 Process / Methodology To Convert Ureas / Sulfonyl Ureas To Chalcogenide Ureas / Sulfonyl Ureas US 63/189,375 Abandoned
NCI E-007-2019-0-US-05 TP5, A PEPTIDE INHIBITOR OF ABERRANT AND HYPERACTIVE CDK5/P25 AS TREATMENT FOR CANCER US National Stage 17/294,011 Abandoned
NHLBI E-127-2021-1-US-01 COMPOSITIONS AND METHODS FOR TREATING SICKLE CELL DISEASES US 63/188,843 Abandoned
NIAID E-357-2001-1-AU-35 CONSTRUCTION OF WEST NILE VIRUS AND DENGUE VIRUS CHIMERAS FOR USE IN A LIVE VIRUS VACCINE TO PREVENT DISEASE CAUSED BY WEST NILE VIRUS AU DIV 2021203089 Expired
NIAID E-104-2020-0-PCT-02 RSV VACCINE BEARING ONE OF MORE P GENE MUTATIONS PCT PCT PCT/US2021/032305 Expired
NIAID E-145-2021-2-PCT-01 Adjuvanted Stabilized Stem Hemagglutinin Nanoparticles And Methods Of Using The Same To Induce Broadly Neutralizing Antibodies Against Influenza PCT PCT COMB PCT/US2021/032252 Expired
NIAID E-104-2020-0-AU-03 RSV VACCINE BEARING ONE OF MORE P GENE MUTATIONS AU National Stage 2021271702 Pending
NHLBI E-127-2021-0-US-01 COMPOSITIONS AND METHODS FOR TREATING SICKLE CELL DISEASES US 63/188,320 Abandoned